Patients' adherence to antiretroviral therapy (ART) is important for effective medical treatment of HIV/AIDS. We conducted a qualitative interview study in the Copperbelt Province of Zambia in 2006. The aim of the study was to explore patients' and health care professionals' perceived barriers and facilitators to patients' adherence to ART. Based on data from individual interviews and focus group interviews with a total of 60 patients and 12 health care professionals, we identified barriers and facilitators related to patients' beliefs and behaviours, the health service, and socio-economic and cultural factors. Among the barriers we identified were lack of communication and information about ART, inadequate time during consultations, lack of follow-up and counselling, forgetfulness, stigma, discrimination and disclosure of HIV status, lack of confidentiality in the treatment centres, and lack of nutritional support.
Introduction
Antiretroviral therapy (ART) has significantly improved the morbidity and mortality of individuals infected with HIV (Palella, Delaney, Moorman, Loveless, Fuhrer, Satten et al., 1998) . However, lack of adherence to highly active antiretroviral therapy (HAART) remains a key challenge to successful management of patients with HIV/AIDS. It is estimated that adherence rates lower than 95% are associated with development of viral resistance to antiretroviral medications (Nachega, Hislop, Dowdy, Chaisson, Regensberg & Maartens, 2007; Oyugi, Byakika-Tusiime, Ragland, Laeyendecker, Mugerwa, Kityo et al., 2007; Wahl & Nowak, 2000) . Adherence has been defined as 'the extent to which a person's behaviour (in terms of taking medications, following diets, or executing lifestyle changes) coincides with medical advice' (Haynes, 1979) . The findings from a recent systematic review indicated that adherence to ART among patients in sub-Saharan Africa compares favourably with adherence rates in North America: among the included African studies (totalling 12 116 patients), 77% of the patients achieved adequate adherence, while the corresponding proportion from North-America was 55 % (17 573 patients) (Mills, Nachega, Buchan, Orbinski, Attaran, Singh et al., 2006) . However, the authors of the review stressed that 'efforts to sustain adherence in Africa and elsewhere remain important goals to optimize outcomes for individuals and global HIV treatment. '
In a systematic review of patients' reported barriers and facilitators to adherence, the authors found that 'fear of disclosure, forgetfulness, a lack of understanding of treatment benefits, complicated regimens, and being away from their medications were consistent barriers to adherence across developed and developing nations. ' (Mills, Nachega, Bangsberg, Singh, Rachlis, Wu et al., 2006) . Barriers that were more specific for developing countries were 'access, including financial constraints and a disruption in access to medications. ' However, among the 37 qualitative studies included in the review, only two were from developing countries, thus the authors concluded that 'Research is urgently needed to determine patient-important factors for adherence in developing world settings. ' Several reports have been published since then from qualitative studies exploring factors that may affect adherence to ART (Hardon, Akurut, Comoro, Ekezie, Irunde & Gerrits et al., 2007; Kumarasamy, Safren, Raminani, Pickard, James, Krishnan et al., 2005; Malta, Petersen, Clair, Freitas & Bastos, 2005; Nachega, Knowlton, Deluca, Schoeman, Waltkinson, Efron et al., 2006) . In an open cohort study of more than 16 000 adult patients that were started on ART in urban Zambia (Lusaka), poor adherence was among the factors found to be strongly correlated with mortality (Stringer, Zulu, Levy, Stinger, Mwango, Chi et al., 2006) .
Adherence to ART in Zambian hospitals is assessed through patient self-reports and monthly reports from pharmacies. To our knowledge no research to identify barriers or facilitators for ART adherence has taken place in Zambia previously. A better understanding of factors that influence patients' adherence to ART can improve treatment programmes of patients with HIV/ AIDS. We conducted a qualitative study with the aim to explore patients' and health care professionals' views on barriers and facilitators to patients' adherence to ART in Zambia.
Methods
Data were collected during fieldwork in Kitwe and Masaiti districts in the Copperbelt Province of Zambia, from August to December 2006. Kitwe is an urban city, whereas Masaiti is a rural town. We conducted focus groups and individual indepth interviews with patients using ART, and health care Original Article 20 years and older, with diverse social backgrounds ( Table 1) .
We also recruited 12 health professionals who had experience with ART, including 3 doctors, 2 clinical officers, 3 nurses, 1 programme co-ordinator for a home-based care programme, and 3 pharmacists ( 
Interviews
We interviewed a total of 72 individuals, 60 patients and 12 health 
Analysis
Audiotapes of the interviews were transcribed verbatim by the first author and assistants. The interviews were translated from Bemba and Lamba, which are the local languages, into
English. All authors read the transcripts from the 10 interviews independently and developed a coding frame for the analysis.
The first author coded all the transcripts, and all the authors independently read the material and contributed in negotiating the final categories and their contents. Material about participants' perceived barriers and facilitators to ART adherence were identified and used for systematic text condensation, according to the principles of Giorgi's (1985) phenomenological analysis, as modified by Malterud (2001) . The analysis followed four steps: (i) reading all the material to obtain an overall impression and bracketing previous conceptions; (ii) identifying units of meaning representing different aspects of participants' perceived barriers and facilitators to adherence, and coding for these units;
(iii) condensing and summarising the contents of each of the coded groups; and (iv) generalising descriptions and concepts concerning barriers and facilitators to ART.
Results
We identified several perceived barriers and facilitators to patients' adherence to ART (Table 3) . We classified our findings into three main themes: (i) factors related to patients' beliefs Some interviewees also knew of patients who had stopped taking their medication because they were overwhelmed by 'pride' , as they were looking physically fit and had regained their health.
Facilitators
Experiencing better health, living longer, knowing health workers personally, and prayers were reported by both patients and health care professionals as factors that facilitated adherence. 
Health services-related factors

Barriers
Lack of communication about ART between health care professionals and patients, time constraints during consultations, lack of counselling skills and patient follow up, lack of infrastructure to conduct counselling, and long distances to health facilities were reported as barriers to adherence. One group of patients said that they had not been informed about how to take their medication when they started using ART.
A 34-year-old female patient, a widow and teacher, explained 
Facilitators
We found that nutritional support, information about ART and free treatment were perceived as facilitators to ART adherence. Patients said the information they received about ART motivated them to take the drugs. This could be information given either by health care professionals or from booklets and workshops.
Provision of free treatment was another facilitator to adherence mentioned by patients. Knowing health workers personally was also reported as a motivating factor for patients to continue taking ART. 
Socio-economic and cultural factors
Discussion
We recruited participants from ART clinics, who were all taking medication or were providing health services at a clinic.
Our findings offer an understanding of the complexity and dynamics of the different factors that may influence patients' adherence to ART. We believe our results may be valid for other settings, although we cannot determine to what extent different factors are important barriers or facilitators in other contexts.
A weakness of our study is that we were not able to interview people who did not seek help at a clinic.
Our study identified barriers and facilitators which were diverse in nature, with a wide spectrum of factors related to patients' beliefs and behaviours, to the health services, and to socio- 
Improvement of health as an ambiguous factor
A striking finding in our study was that patients' feeling of improved health could be a barrier as well as a facilitator to adherence. Patients were said not to continue taking their medication when they felt better. However, patients and health care professionals also mentioned that patients were motivated to continue taking their medications when they began to feel better after being started on ART. Improvement of subjective health has to be understood in the context of patients' beliefs about the treatment and how well informed they were. Some patients believed they were healed and therefore did not understand why they should continue taking their medication. Earlier studies also reported that feeling better could act as a barrier or as a facilitator to adherence (Mills, Nachega, Bangsberg et al., 2006) . Adherence counselling is commonly offered to patients at the start of ART. However, these findings indicate that the stage of treatment when patients are starting to feel better could be a critical turning point with regards to adherence. Thus, counselling activities that specifically target patients during this treatment phase may be worth considering.
Communication about medication
Lack of communication and information about ART emerged as a barrier to adherence in our study. Most patients and some health care professionals mentioned that patients received little or no information about their medication from their health care
providers. Other studies have also found that poor or lack of communication was a barrier to adherence to ART (Malta et al., 2005) .
Confidentiality
Confidentiality at treatment centres, especially at pharmacies, was another issue that emerged from our study. While the pharmacies were used as information dissemination centres for ART adherence, most patients did not favour such an approach.
In some health facilities, the pharmacy for dispensing ART was different from the general pharmacy, which made patients feel labelled by their health institutions. This illustrates the importance of taking confidentiality and stigma issues into consideration when the provision of ART is being scaled up.
Stigma
We found that some patients and health care professionals experienced that stigma was still widespread in their local communities. Stigma and social exclusion has also been highlighted in other studies as a barrier to adherence to ART (Kumarasamy et al., 2005) . Fear of disclosure of HIV/AIDS status or being seen taking medication was identified as a barrier to adherence in previous studies (Mills, Nachega, Bangsberg et al., 2006; Nachega et al., 2006) , and this was also mentioned by one group of patients in our study. For others, however, disclosure was reported as a facilitator to adherence. Disclosure can mobilise support from spouses, families and communities, and can motivate patients to take their medication (Mills, Nachega, Bangsberg et al., 2006) .
Nutritional support
Nutritional support emerged as an important factor for ART adherence. Lack of food was mentioned by both patients and health care professionals as a cause of non-adherence, and nutritional support was mentioned as a facilitator. However, most health facilities did not provide nutritional support to their patients on ART. Lack of food has been identified before in some studies as a factor responsible for patients defaulting from their treatments (Hardon et al., 2007; Nachega et al., 2006) .
Conclusion
Patients' adherence to ART is influenced by a wide variety of factors related to patients' beliefs and behaviour, the health system, and social and cultural issues. Further research is providers. Also, future studies should assess the magnitude of non-adherence to ART in Zambia using quantitative measures.
Our findings can inform the design of interventions to promote adherence to ART. However, the complexity of factors acting as barriers and/or facilitators to treatment adherence imply that the effectiveness of such interventions are unpredictable and need to be evaluated rigorously, preferably in randomised controlled trials.
